Frontiers | Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents
Cancers | Free Full-Text | ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
DDRC Lung Cancer Brochure
Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma - ScienceDirect
A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications | Breast Cancer Research | Full Text
HER2 Oncogenic mutations and amplifications are common across many Indian solid tumors – Sapien Biosciences
Cancers | Free Full-Text | Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Copy number profile of non-small-cell lung cancer tumor sample... | Download Scientific Diagram
CIMB | Free Full-Text | ERBB2-Mutant Gastrointestinal Tumors Represent Heterogeneous Molecular Biology, Particularly in Microsatellite Instability, Tumor Mutation Burden, and Co-Mutated Genes: An In Silico Study
Cancers | Free Full-Text | HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
A reason why the ERBB2 gene is amplified and not mutated in breast cancer | Cancer Cell International | Full Text
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung | Modern Pathology
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports
Reactome | Signaling by ERBB2 in Cancer
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review - ScienceDirect
HER2 amplification in advanced NSCLC patients | OTT
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Patients with Non-small Cell Lung Cancer of Squamous Histology: Focus on Afatinib - touchONCOLOGY
ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy - Modern Pathology
ErbB2 Receptor in Breast Cancer: Implications in Cancer Cell Migration, Invasion and Resistance to Targeted Therapy | IntechOpen
Cancers | Free Full-Text | ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
Frontiers | Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
Pharmaceuticals | Free Full-Text | HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia | Leukemia
Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports
Figure 1 from MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test | Cellular Oncology
